Login to Your Account

Can Flu Vaccine Hole Be Filled?

Fluvirin Mistake Hurts U.S. Plans, Chiron's Credibility

By Brady Huggett

Monday, October 11, 2004

It's one thing to report drug production problems and suffer a stock drop - that happens often in the biotech sector - but it's quite another to push the entire U.S. toward a public health crisis. Last week, Chiron Corp. had the distinct dishonor of doing both.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription